PO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020
HeartRhythm
APRIL 30, 2024
Since its first Food and Drug Administration (FDA) approval in 2016, there has been a significant uptrend in the utilization of leadless pacemakers (LL-PPM).
Let's personalize your content